Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fei Wu, Hao Ning, Yang Sun, Haihu Wu & Jiaju Lyu. (2023) Integrative exploration of the mutual gene signatures and immune microenvironment between benign prostate hyperplasia and castration-resistant prostate cancer. The Aging Male 26:1.
Read now
Read now
Articles from other publishers (11)
G. Cr?hange, M. RoachIIIIII, ?. Martin, L. Cormier, D. Peiffert, A. Cochet, O. Chapet, S. Supiot, J.-M. Cosset, M. Bolla & H.T. Chung. (2014) Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: Who, when, where and how?. Cancer/Radioth?rapie 18:5-6, pages 524-534.
Crossref
Crossref
Frank Kunath, Henrik R Grobe, Gerta Rücker, Edith Motschall, Gerd Antes, Philipp Dahm, Bernd Wullich & Joerg J Meerpohl. (2014) Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. Cochrane Database of Systematic Reviews.
Crossref
Crossref
M. Picchio, G. Berardi, A. Fodor, E. Busnardo, C. Crivellaro, G. Giovacchini, C. Fiorino, M. Kirienko, E. Incerti, C. Messa, L. Gianolli & N. Di Muzio. (2014) 11C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging.
Crossref
Crossref
Ute Ganswindt & Claus Belka. 2015. Radiotherapy in Prostate Cancer. Radiotherapy in Prostate Cancer
111
122
.
Antonella Pepe, Michael Pamment, Yeong Sang Kim, Sunmin Lee, Min-Jung Lee, Kristin Beebe, Anton Filikov, Len Neckers, Jane B. Trepel & Sanjay V. Malhotra. (2013) Synthesis and Structure–Activity Relationship Studies of Novel Dihydropyridones as Androgen Receptor Modulators. Journal of Medicinal Chemistry 56:21, pages 8280-8297.
Crossref
Crossref
Gilles Créhange, Chien Peter Chen, Charles C. Hsu, Norbert Kased, Fergus V. Coakley, John Kurhanewicz & Mack RoachIIIIII. (2012) Management of prostate cancer patients with lymph node involvement: A rapidly evolving paradigm. Cancer Treatment Reviews 38:8, pages 956-967.
Crossref
Crossref
Barbara A. Jereczek-Fossa, Laura Fariselli, Giancarlo Beltramo, Gianpiero Catalano, Flavia Serafini, Cristina Garibaldi, Raffaella Cambria, Lorenzo Brait, Marco Possanzini, Livia C. Bianchi, Andrea Vavassori, Dario Zerini, Franco Orsi, Ottavio de Cobelli & Roberto Orecchia. (2009) Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer. Radiotherapy and Oncology 93:1, pages 14-17.
Crossref
Crossref
G. Shaw & R.T.D. Oliver. (2009) Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer. Surgical Oncology 18:3, pages 275-282.
Crossref
Crossref
Dhande Sudhakar Reddy, Norio Shibata, Jun Nagai, Shuichi Nakamura & Takeshi Toru. (2009) A Dynamic Kinetic Asymmetric Transformation in the α-Hydroxylation of Racemic Malonates and Its Application to Biologically Active Molecules. Angewandte Chemie International Edition 48:4, pages 803-806.
Crossref
Crossref
Dhande Sudhakar Reddy, Norio Shibata, Jun Nagai, Shuichi Nakamura & Takeshi Toru. (2009) A Dynamic Kinetic Asymmetric Transformation in the α-Hydroxylation of Racemic Malonates and Its Application to Biologically Active Molecules. Angewandte Chemie 121:4, pages 817-820.
Crossref
Crossref
Nicola Antonio Colabufo, Vincenzo Pagliarulo, Francesco Berardi, Marialessandra Contino, Carmela Inglese, Mauro Niso, Patrizia Ancona, Giancarlo Albo, Arcangelo Pagliarulo & Roberto Perrone. (2008) Bicalutamide failure in prostate cancer treatment: Involvement of Multi Drug Resistance proteins. European Journal of Pharmacology 601:1-3, pages 38-42.
Crossref
Crossref